Search

Claude A Ogoe

from Matawan, NJ
Age ~47
Get Report
Related to:
Esther N Odoe, 69Felicia T Odoe, 41John Ogoe, 32John Coleman, 42Clara J Coleman, 62John Coleman, 75Donald Parham, 57Meredith Coleman, 74
Connected to:
Finbarrs C Ogoh, 62Doriscilla A Ogola, 46Melchizedeck F Ogola, 68Tom Ogola, 55Daniel B Ogomori, 65James R Ogonosky, 63Nicole Ogonoski, 51Brenda L Ogonowski, 54Susan L Ogonowski, 51Osborn O Ogonyo, 50

Claude Ogoe Phones & Addresses

  • Matawan, NJ
  • Philadelphia, PA
  • Pittsburgh, PA
  • 214 Stearns Hill Rd, Waltham, MA 02451 (781) 373-5731
  • 4615 Stearns Hill Rd, Waltham, MA 02451 (781) 373-5731 (781) 609-2163
  • Meadville, PA
  • 5413 Kentucky Ave APT 4, Pittsburgh, PA 15232

Work

Company: Fmc corporation Jul 1, 2014 Position: Mba ldp associate

Education

Degree: Master of Business Administration, Masters School / High School: Carnegie Mellon University - Tepper School of Business 2012 to 2014

Skills

Drug Development • Organic Synthesis • Pharmaceutical Industry • Drug Discovery • Business Strategy • Medicinal Chemistry • Strategy • Nmr • Biochemistry • Data Analysis • Cross Functional Team Leadership • Lead Change • Organic Chemistry • Biotechnology • Cancer • Drug Design

Languages

English • French

Industries

Pharmaceuticals

Resumes

Resumes

Claude Ogoe Photo 1

Mba Ldp Associate

View page
Location:
Pittsburgh, PA
Industry:
Pharmaceuticals
Work:
Fmc Corporation
Mba Ldp Associate
Medtronic Nov 2013 - May 2014
Intern
Astrazeneca R&D Jul 2006 - 2012
Medicinal Chemist
Education:
Carnegie Mellon University - Tepper School of Business 2012 - 2014
Master of Business Administration, Masters University of Pittsburgh 2003 - 2006
Master of Science, Masters, Organic Chemistry Allegheny College 1999 - 2003
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Development
Organic Synthesis
Pharmaceutical Industry
Drug Discovery
Business Strategy
Medicinal Chemistry
Strategy
Nmr
Biochemistry
Data Analysis
Cross Functional Team Leadership
Lead Change
Organic Chemistry
Biotechnology
Cancer
Drug Design
Languages:
English
French

Publications

Us Patents

3-Cinnolinecarboxamide Derivatives And Their Use For Treating Cancer

View page
US Patent:
20090012084, Jan 8, 2009
Filed:
Sep 15, 2008
Appl. No.:
12/210588
Inventors:
Leslie Dakin - Waltham MA, US
Claude Afona Ogoe - Waltham MA, US
David Scott - Waltham MA, US
XiaoLan Zheng - Waltham MA, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/502
C07D 237/28
A61K 31/5377
A61P 35/00
C07D 413/02
US Classification:
5142345, 544235, 544119, 514248
Abstract:
The invention relates to chemical compounds of formula (I):or pharmaceutically acceptable salts thereof which possess CSF-1R kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.

Chemical Compounds

View page
US Patent:
20090270450, Oct 29, 2009
Filed:
May 5, 2009
Appl. No.:
12/435856
Inventors:
Leslie Dakin - Waltham MA, US
Kevin Daly - Waltham MA, US
David Del Valle - Austin TX, US
Thomas Gero - Waltham MA, US
Claude Afona Ogoe - Waltham MA, US
David Scott - Waltham MA, US
Xiaolan Zheng - Waltham MA, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/47
C07D 215/44
US Classification:
514313, 546160
Abstract:
The invention relates to chemical compounds of formula (I):or pharmaceutically acceptable salts thereof which possess CSF-1R kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.

3-Cinnolinecarboxamide Derivatives And Their Use For Treating Cancer

View page
US Patent:
20110098283, Apr 28, 2011
Filed:
May 17, 2010
Appl. No.:
12/781277
Inventors:
Leslie Dakin - Waltham MA, US
Claude Afona Ogoe - Waltham MA, US
David Scott - Waltham MA, US
XiaoLan Zheng - Waltham MA, US
International Classification:
A61K 31/502
C07D 237/28
C07D 401/10
C07D 403/10
C07D 413/10
A61K 31/55
A61K 31/5377
A61P 35/00
C12N 9/99
US Classification:
514218, 544235, 540575, 544119, 514248, 5142345, 514249, 435184
Abstract:
The invention relates to chemical compounds of formula (I):or pharmaceutically acceptable salts thereof which possess CSF-1R kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.

Chemical Compounds

View page
US Patent:
20120035134, Feb 9, 2012
Filed:
Aug 5, 2011
Appl. No.:
13/198764
Inventors:
Robert Bruce DIEBOLD - Waltham MA, US
Thomas GERO - Waltham MA, US
Paul GROVER - Waltham MA, US
Shan HUANG - Waltham MA, US
Stephanos IOANNIDIS - Waltham MA, US
Claude Afona OGOE - Waltham MA, US
Jamal Carlos SAEH - Waltham MA, US
Jeffrey Gilbert VARNES - Waltham MA, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/675
C07D 401/12
C07F 9/02
A61P 35/00
A61K 31/445
A61K 31/497
A61K 31/5377
C07D 211/32
C07D 413/12
US Classification:
514 85, 546247, 544360, 544337, 544130, 514315, 51425301, 5142355
Abstract:
The present invention relates to compounds of Formula (I):and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-Xactivities and may be used for the treatment of cancer.

N-Acylsulfonamide Apoptosis Promoters

View page
US Patent:
20130310344, Nov 21, 2013
Filed:
Aug 5, 2011
Appl. No.:
13/814318
Inventors:
Robert Bruce Diebold - Waltham MA, US
Thomas Gero - Waltham MA, US
Paul Grover - Waltham MA, US
Shan Huang - Waltham MA, US
Stephanos Ioannidis - Waltham MA, US
Claude Afona Ogoe - Waltham MA, US
Jamal Carlos Saeh - Waltham MA, US
Jeffrey Gilbert Varnes - Waltham MA, US
Assignee:
ASTRAZENECA AB - Cheshire
International Classification:
C07D 211/34
C07F 9/59
C07D 413/12
US Classification:
514 90, 514 85, 514 89, 514156, 514157, 544130, 544337, 544360, 546 22, 546234
Abstract:
The present invention relates to compounds of Formula (I): and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-Xactivities and may be used for the treatment of cancer.

Chemical Compounds

View page
US Patent:
20160176906, Jun 23, 2016
Filed:
Dec 15, 2015
Appl. No.:
14/969775
Inventors:
- Sodertalje, SE
Thomas Woodrow Gero - Waltham MA, US
Paul Grover - Waltham MA, US
Shan Huang - Waltham MA, US
Stephanos Ioannidis - Waltham MA, US
Claude Afona Ogoe - Waltham MA, US
Jamal Carlos Saeh - Waltham MA, US
Jeffrey Gilbert VARNES - Waltham MA, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
C07F 9/6558
C07F 9/58
C07F 9/6509
C07D 211/22
Abstract:
The present invention relates to compounds of Formula (I):and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-Xactivities and may be used for the treatment of cancer.

Chemical Compounds

View page
US Patent:
20150328239, Nov 19, 2015
Filed:
Feb 18, 2015
Appl. No.:
14/625009
Inventors:
- Sodertalje, SE
Thomas Woodrow Gero - Waltham MA, US
Paul Grover - Waltham MA, US
Shan Huang - Waltham MA, US
Stephanos Ioannidis - Waltham MA, US
Claude Afona Ogoe - Waltham MA, US
Jamal Carlos Saeh - Waltham MA, US
Jeffrey Gilbert VARNES - Waltham MA, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/675
A61K 31/451
A61K 31/5377
A61K 31/496
Abstract:
The present invention relates to compounds of Formula (I):and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-Xactivities and may be used for the treatment of cancer.
Control profile
Claude A Ogoe from Matawan, NJ, age ~47 Get Report